Home / Actual products: Co / COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/...
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/...
- ID
- 39114911000001105
- Virtual product
- Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials
- Name
- COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials
- Abbreviated name
- COVID-19 Vaccine Vaxzevria 0.5ml inj multidose vials
- Description
- COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)
- Date of name applicability
- 10 May 2022
- Previous Name
- COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials
- Supplier
- AstraZeneca UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- Previously licensed as
- None
- License change reason
- Licence Granted
- Date of change of licensing authority
- 5 Jan 2021
- EMA (European Medicines Agency) Monitoring
- 1
- Restrictions on availability
- Restricted Availability
- Licensed route
- Intramuscular